The DOI matches its Crossref record; 271 of the 280 references it cites were found in a registry or an index.
Cyclers’ kinases in cell division: from molecules to cancer therapy
Open accessAbstract
Faithful eucaryotic cell division requires spatio-temporal orchestration of multiple sequential events. To ensure the dynamic nature of these molecular and morphological transitions, a swift modulation of key regulatory pathways is necessary. The molecular process that most certainly fits this description is phosphorylation, the post-translational modification provided by kinases, that is crucial to allowing the progression of the cell cycle and that culminates with the separation of two identical daughter cells. In detail, from the early stages of the interphase to the cytokinesis, each critical step of this process is tightly regulated by multiple families of kinases including the Cyclin-dependent kinases (CDKs), kinases of the Aurora, Polo, Wee1 families, and many others. While cell-cycle-related CDKs control the timing of the different phases, preventing replication machinery errors, the latter modulate the centrosome cycle and the spindle function, avoiding karyotypic abnormalities typical of chromosome instability. Such chromosomal abnormalities may result from replication stress (RS) and chromosome mis-segregation and are considered a hallmark of poor prognosis, therapeutic resistance, and metastasis in cancer patients. Here, we discuss recent advances in the understanding of how different families of kinases concur to govern cell cycle, preventing RS and mitotic infidelity. Additionally, considering the growing number of clinical trials targeting these molecules, we review to what extent and in which tumor context cell-cycle-related kinases inhibitors are worth exploiting as an effective therapeutic strategy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Aberrant CDK activation plays a critical role in KRAS-mediated oncogenic signaling.”
From Differential Response and Resistance to KRAS-Targeted Therapy (2025) · cites this paper as [119]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Wang, Y., Luo, R., Zhang, X., Xiang, H., Yang, B., Feng, J., Deng, M., Ran, P., Sujie, A., Zhang, F., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-36005-1 · Cited by 49
RetractedCerami, E., Gao, J., Dogrusoz, U., Gross, B. E., Sumer, S. O., Aksoy, B. A., Jacobsen, A., Byrne, C. J., Heuer, M. L., Larsson, E., et al. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0095 · Cited by 17,455
Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
Gao, J., Aksoy, B. A., Dogrusoz, U., Dresdner, G., Gross, B., Sumer, S. O., Sun, Y., Jacobsen, A., Sinha, R., Larsson, E., et al. (2013) · Science Signaling · doi:10.1126/scisignal.2004088 · Cited by 15,160
A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4.
Serrano, M., Hannon, G. J., & Beach, D. (1993) · Nature · doi:10.1038/366704a0 · Cited by 3,650
ATM and ATR Substrate Analysis Reveals Extensive Protein Networks Responsive to DNA Damage
Matsuoka, S., Ballif, B. A., Smogorzewska, A., McDonald, E. R., Hurov, K. E., Luo, J., Bakalarski, C. E., Zhao, Z., Solimini, N., Lerenthal, Y., et al. (2007) · Science · doi:10.1126/science.1140321 · Cited by 3,075
A Single Ataxia Telangiectasia Gene with a Product Similar to PI-3 Kinase
Savitsky, K., Bar-Shira, A., Gilad, S., Rotman, G., Ziv, Y., Vanagaite, L., Tagle, D. A., Smith, S., Uziel, T., Sfez, S., et al. (1995) · Science · doi:10.1126/science.7792600 · Cited by 2,785 · cited 1×
“ATM has been first discovered in a patient affected by Ataxia Telangiectasia (AT) in 1995, and was found to encode a large protein of approximately 350 kDa [83].”
BackgroundAACR Project GENIE: Powering Precision Medicine through an International Consortium
The AACR Project GENIE Consortium, The AACR Project GENIE Consortium, André, F., Arnedos, M., Baras, A. S., Baselga, J., Bedard, P. L., Berger, M. F., Bierkens, M., Calvo, F., et al. (2017) · Cancer Discovery · doi:10.1158/2159-8290.cd-17-0151 · Cited by 1,964 · cited 3×
“06% of AACR GENIE cases, with gastric adenocarcinoma, conventional glioblastoma multiforme, de-differentiated liposarcoma, lung adenocarcinoma, and with lung pleomorphic carcinoma having the greatest prevalence [69].”
BackgroundInfluentialMalumbres, M. (2014) · Genome Biology · doi:10.1186/gb4184 · Cited by 1,654
Liu, Q., Guntuku, S., Cui, X.-S., Matsuoka, S., Cortez, D., Tamai, K., Luo, G., Carattini-Rivera, S., DeMayo, F., Bradley, A., et al. (2000) · Genes & Development · doi:10.1101/gad.14.12.1448 · Cited by 1,625
DNA Damage Sensing by the ATM and ATR Kinases
Marechal, A., & Zou, L. (2013) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a012716 · Cited by 1,514
Cited by
Aurora kinases signaling in cancer: from molecular perception to targeted therapies
Vats, P., Saini, C., Baweja, B., Srivastava, S. K., Kumar, A., Kushwah, A. S., & Nema, R. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02353-3 · Cited by 59
Yang, Z., Yang, Z., Bakar, M. Z. A., & Deng, X. (2025) · Microchemical Journal · doi:10.1016/j.microc.2025.112917 · Cited by 22
Exploring the landscape of post-translational modification in drug discovery
Cao, Y., Yu, T., Zhu, Z., Zhang, Y., Sun, S., Li, N., Gu, C., & Yang, Y. (2024) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2024.108749 · Cited by 21
Gomez-Raya-Vilanova, M. V., Teulière, J., Medvedeva, S., Dai, Y., Corel, E., Lopez, P., Lapointe, F., Bhattacharya, D., Haraoui, L., Turc, É., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-60613-8 · Cited by 16
Hon, K. W., Nag, S., Stany, B. K., Mishra, S., & Naidu, R. (2025) · Food Bioscience · doi:10.1016/j.fbio.2025.106313 · Cited by 15
Metadata
- Authors
- Milletti, G., Colicchia, V., & Cecconi, F.
- Affiliations
- Bambino Gesù Children's Hospital (IT)
- University of Rome Tor Vergata (IT)
- Università Cattolica del Sacro Cuore (IT)
- Corresponding author
- Milletti, Giacomo
- Cecconi, Francesco
- Venue
- Cell Death & Differentiation
- Published
- 2023-07-29
- Volume
- 30
- Issue
- 9
- Pages
- 2035-2052
- ISSN
- 1350-9047 (ISSN-L)
- 1476-5403
- PMC
- PMC10482880
- OpenAlex
- W4385380106
- Cited by
- 39
- References
- 280
- Citations by year
- 2026: 8 · 2025: 19 · 2024: 11 · 2023: 1
- FWCI
- 1.26
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Cell Death and Differentiation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Novo Nordisk Fonden (NNF21OC0070834)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Microtubule and mitosis dynamics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Keywords
- cell cycle regulation, cyclin-dependent kinases, Aurora kinases, Polo-like kinase, WEE1, kinases, phosphorylation, cytokinesis, chromosomal instability, replication stress, chromosome missegregation, kinase inhibitors, cancer therapy
- MeSH terms
- Cell Cycle, Humans, Mitosis, Neoplasms, Protein Serine-Threonine Kinases, Cell Cycle Proteins, Cyclin-Dependent Kinases, Chromosome Segregation, Aurora Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cyclers’ kinases in cell division: from molecules to cancer therapy. https://app.cochat.ai/papers/10.1038/s41418-023-01196-z
- The paper
- Milletti, G., Colicchia, V., & Cecconi, F. (2023). Cyclers’ kinases in cell division: from molecules to cancer therapy. Cell Death & Differentiation. https://doi.org/10.1038/s41418-023-01196-z
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.